
Aiden Y. Lee
Examiner (ID: 746, Phone: (571)270-1440 , Office: P/1718 )
| Most Active Art Unit | 1718 |
| Art Unit(s) | 1718, 1713 |
| Total Applications | 525 |
| Issued Applications | 210 |
| Pending Applications | 69 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9936862
[patent_doc_number] => 08986667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Cosmetic composition with skin tightening effect'
[patent_app_type] => utility
[patent_app_number] => 12/585755
[patent_app_country] => US
[patent_app_date] => 2009-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5870
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12585755
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585755 | Cosmetic composition with skin tightening effect | Sep 23, 2009 | Issued |
Array
(
[id] => 6375606
[patent_doc_number] => 20100076035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Transdermal Drug Delivery using an Osmolyte and Vasoactive Agent'
[patent_app_type] => utility
[patent_app_number] => 12/564841
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6426
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076035.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564841 | Transdermal drug delivery using an osmolyte and vasoactive agent | Sep 21, 2009 | Issued |
Array
(
[id] => 9608303
[patent_doc_number] => 08785471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/058738
[patent_app_country] => US
[patent_app_date] => 2009-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4959
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058738
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058738 | Pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof | Sep 8, 2009 | Issued |
Array
(
[id] => 6223029
[patent_doc_number] => 20100056536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'METHOD OF TREATING ATRIAL FIBRILLATION'
[patent_app_type] => utility
[patent_app_number] => 12/553841
[patent_app_country] => US
[patent_app_date] => 2009-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9584
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12553841
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553841 | METHOD OF TREATING ATRIAL FIBRILLATION | Sep 2, 2009 | Abandoned |
Array
(
[id] => 6219950
[patent_doc_number] => 20100055045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/547406
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25046
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055045.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547406
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547406 | METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS | Aug 24, 2009 | Abandoned |
Array
(
[id] => 7685433
[patent_doc_number] => 20100120708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 12/541647
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5406
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12541647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541647 | Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy | Aug 13, 2009 | Abandoned |
Array
(
[id] => 6455943
[patent_doc_number] => 20100105743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Pharmaceutical compositions and methods for stabilizing the same'
[patent_app_type] => utility
[patent_app_number] => 12/462147
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6199
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105743.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462147 | Pharmaceutical compositions and methods for stabilizing the same | Jul 29, 2009 | Abandoned |
Array
(
[id] => 6321601
[patent_doc_number] => 20100113534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same'
[patent_app_type] => utility
[patent_app_number] => 12/511631
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5953
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113534.pdf
[firstpage_image] =>[orig_patent_app_number] => 12511631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/511631 | Pharmaceutical Compositions And Methods For Producing Low Impurity Concentrations Of The Same | Jul 28, 2009 | Abandoned |
Array
(
[id] => 6483721
[patent_doc_number] => 20100008968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/492579
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 51779
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008968.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492579 | METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 6248968
[patent_doc_number] => 20100137284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same'
[patent_app_type] => utility
[patent_app_number] => 12/492018
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8231
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137284.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492018 | Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same | Jun 24, 2009 | Abandoned |
Array
(
[id] => 5398489
[patent_doc_number] => 20090318552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizo dor treating or preventing diabetes mellitus and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/456171
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5922
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12456171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456171 | Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizo dor treating or preventing diabetes mellitus and the use thereof | Jun 11, 2009 | Abandoned |
Array
(
[id] => 8807844
[patent_doc_number] => 08445495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Certain Chemical entities, compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 12/483093
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48475
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12483093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483093 | Certain Chemical entities, compositions and methods | Jun 10, 2009 | Issued |
Array
(
[id] => 5570361
[patent_doc_number] => 20090253739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Amine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/481891
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28376
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253739.pdf
[firstpage_image] =>[orig_patent_app_number] => 12481891
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/481891 | Amine Derivatives | Jun 9, 2009 | Abandoned |
Array
(
[id] => 5973057
[patent_doc_number] => 20110152323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'Histone deacetylase inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/000186
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30726
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152323.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000186
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000186 | Histone deacetylase inhibitors and uses thereof | Jun 8, 2009 | Issued |
Array
(
[id] => 7663715
[patent_doc_number] => 20110312984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'STAT3 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/996073
[patent_app_country] => US
[patent_app_date] => 2009-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 33592
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312984.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996073
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996073 | STAT3 INHIBITORS | Jun 2, 2009 | Abandoned |
Array
(
[id] => 6637543
[patent_doc_number] => 20100173875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral adminstration for the treatment of cardiovascular and other disease states'
[patent_app_type] => utility
[patent_app_number] => 12/454847
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4757
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173875.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454847
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454847 | Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral administration for the treatment of cardiovascular and other disease states | May 25, 2009 | Issued |
Array
(
[id] => 6496740
[patent_doc_number] => 20100010096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Methadone chiral isolate as an improved pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 12/454373
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1405
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010096.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454373 | Methadone chiral isolate as an improved pharmaceutical | May 17, 2009 | Abandoned |
Array
(
[id] => 5304271
[patent_doc_number] => 20090298923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Salicylate Conjugates Useful for Treating Metabolic Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/465201
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 35346
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298923.pdf
[firstpage_image] =>[orig_patent_app_number] => 12465201
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/465201 | Salicylate Conjugates Useful for Treating Metabolic Disorders | May 12, 2009 | Abandoned |
Array
(
[id] => 5404739
[patent_doc_number] => 20090240054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Rosuvastatin calcium with a low salt content'
[patent_app_type] => utility
[patent_app_number] => 12/387605
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6992
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20090240054.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387605 | Rosuvastatin calcium with a low salt content | May 3, 2009 | Abandoned |
Array
(
[id] => 5515499
[patent_doc_number] => 20090215806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Rosuvastatin calcium with a low salt content'
[patent_app_type] => utility
[patent_app_number] => 12/387634
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6988
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215806.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387634 | Rosuvastatin calcium with a low salt content | May 3, 2009 | Abandoned |